Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Propagation of venous thrombi or rethrombosis after coronary thrombolytic therapy can occur despite heparin administration. To explore potential mechanisms, we set out to determine whether clot-bound thrombin is relatively protected from inhibition by heparin-antithrombin III but susceptible to inac...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	J Clin Invest
Asıl Yazarlar:	Weitz, J I, Hudoba, M, Massel, D, Maraganore, J, Hirsh, J
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Clinical Investigation 1990
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2384594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114723
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!